Human Papillomavirus Vaccine (HPV) Market Revenue to Surpass US$ 7.71 Billion by 2034
Safety monitoring systems worldwide consistently confirm that the HPV vaccine is well tolerated. Most reported side effects are mild and temporary, such as soreness at the injection site, low-grade fever, or fatigue. Extensive post-marketing surveillance and clinical research have reinforced confidence in its safety and effectiveness across diverse populations.
Market Overview
The Human...